Exosens Shares Drop 12.25% Over the Week and Enter Oversold Territory at €57.30
Exosens shares fell by 1.88% to €57.30 mid-morning, in an SBF 120 that lost 0.64% at 6,090.16 points. The specialist in night vision and imaging technologies for defense extends a downward trend that began last week. The weekly decline reaches 12.25%, but the annual performance remains positive at 64.18%.
A Tight Technical Setup Below the Lower Bollinger Band
The price has moved below the lower Bollinger band, set at €59.80, indicating an oversold signal after several sessions of decline. The RSI at 35 confirms the exhaustion of the selling trend, without yet triggering a rebound. The stock is now significantly below its 20 and 50-day moving averages, both around €64, representing a gap of approximately 11%. The 200-day moving average at €51.13 remains at a distance and represents a medium-term support. The technical support identified at €57.50 is in contact with the current price, making it the observed zone in the session.
A Clear Schedule and Tight Valuation
No publications are expected in the short term: the annual general meeting will be held on May 22, 2026, followed by the first-half results on July 28, 2026. The latest business update, published on April 29, reported a 19.7% increase in revenue for the first quarter, at €122.6 million. In terms of valuation, the stock is trading at about 30.5 times the expected earnings for the current fiscal year and 25.7 times those for the next fiscal year, compared to a sector average (Industrials) of 18.4 times. The expected growth in earnings per share from one year to the next is 18.4%. The stock is in the lower half of the SBF 120 this Tuesday, ranked 109th out of 120, without being among the index's sharpest declines. The next formal appointment: the general meeting on May 22.
